Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model

DMM Disease Models and Mechanisms

Volumn 6, Issue 5, 2013, Pages 1198-1204

  Dang, Theresa N T ^a   Dobson Stone, Carol ^b,c   Glaros, Elias N ^c   Kim, Woojin S ^b,c   Hallupp, Marianne ^b   Bartley, Lauren ^b   Piguet, Olivier ^b,c   Hodges, John R ^b,c   Halliday, Glenda M ^b,c   Double, Kay L ^b,c   Schofield, Peter R ^b,c   Crouch, Peter J ^a   Kwok, John B J ^b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE; TAR DNA BINDING PROTEIN; TAU PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CORTICOBASAL SYNDROME; FRONTOTEMPORAL DEMENTIA; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOTOR NEURON DISEASE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; TARDBP GENE;

AGED; AMINO ACID SUBSTITUTION; ANIMALS; COHORT STUDIES; DEMOGRAPHY; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MIDDLE AGED; MOTOR ACTIVITY; PROGESTERONE; TAU PROTEINS;

EID: 84883886000     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.011460     Document Type: Article

References (32)

1. Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B 57, 289-300.
2. Boeve, B. F. (2007). Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis. Assoc. Disord. 21, S31-S38.
3. Boillée, S., Vande Velde, C. and Cleveland, D. W. (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59.
4. Borroni, B., Archetti, S., Del Bo, R., Papetti, A., Buratti, E., Bonvicini, C., Agosti, C., Cosseddu, M., Turla, M., Di Lorenzo, D. et al. (2010). TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. Rejuvenation Res. 13, 509-517.
5. Burrell, J. R., Kiernan, M. C., Vucic, S. and Hodges, J. R. (2011). Motor neuron dysfunction in frontotemporal dementia. Brain 134, 2582-2594.
6. Carroll, J. C., Rosario, E. R., Villamagna, A. and Pike, C. J. (2010). Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology 151, 2713-2722.
7. Dennis, J. S. and Citron, B. A. (2009). Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein. Neuroscience 158, 745-750.
8. Frye, C. A. and Walf, A. A. (2009). Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease. Age (Dordr.) 31, 143-153.
9. Gargiulo Monachelli, G., Meyer, M., Rodríguez, G. E., Garay, L. I., Sica, R. E., De Nicola, A. F. and González Deniselle, M. C. (2011). Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurol. Scand. 123, 60-67.
10. Gonzalez Deniselle, M. C., López-Costa, J. J., Saavedra, J. P., Pietranera, L., Gonzalez, S. L., Garay, L., Guennoun, R., Schumacher, M. and De Nicola, A. F. (2002). Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11, 457-468.
11. Goodall, E. F. and Morrison, K. E. (2006). Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev. Mol. Med. 8, 1-22.
12. Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F. et al. (2011). Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
13. Guo, Y. S., Wang, Q., Zhang, K. X., An, T., Shi, P. X., Li, Z. Y., Duan, W. S. and Li, C. Y. (2012). HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 1460, 88-95.
14. Henry, M. S., Passmore, A. P., Todd, S., McGuinness, B., Craig, D. and Johnston, J. A. (2013). The development of effective biomarkers for Alzheimer's disease: a review. Int. J. Geriatr. Psychiatry 28, 331-340.
15. Hodges, J. R., Davies, R. R., Xuereb, J. H., Casey, B., Broe, M., Bak, T. H., Kril, J. J. and Halliday, G. M. (2004). Clinicopathological correlates in frontotemporal dementia. Ann. Neurol. 56, 399-406.
16. Kipp, M., Amor, S., Krauth, R. and Beyer, C. (2012). Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender. Front. Neuroendocrinol. 33, 1-16.
17. Kouri, N., Whitwell, J. L., Josephs, K. A., Rademakers, R. and Dickson, D. W. (2011). Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol. 7, 263-272.
18. Lillo, P. and Hodges, J. R. (2009). Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J. Clin. Neurosci. 16, 1131-1135.
19. Luty, A. A., Kwok, J. B., Dobson-Stone, C., Loy, C. T., Coupland, K. G., Karlström, H., Sobow, T., Tchorzewska, J., Maruszak, A., Barcikowska, M. et al. (2010). Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann. Neurol. 68, 639-649.
20. Mackenzie, I. R., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E. et al. (2010). Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1-4.
21. Mioshi, E., Hsieh, S., Savage, S., Hornberger, M. and Hodges, J. R. (2010). Clinical staging and disease progression in frontotemporal dementia. Neurology 74, 1591-1597.
22. Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U. et al. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477.
23. Ratnavalli, E., Brayne, C., Dawson, K. and Hodges, J. R. (2002). The prevalence of frontotemporal dementia. Neurology 58, 1615-1621.
24. Schmitt-John, T., Drepper, C., Mussmann, A., Hahn, P., Kuhlmann, M., Thiel, C., Hafner, M., Lengeling, A., Heimann, P., Jones, J. M. et al. (2005). Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 37, 1213-1215.
25. Schofield, E. C., Hodges, J. R., Bak, T. H., Xuereb, J. H. and Halliday, G. M. (2012). The relationship between clinical and pathological variables in Richardson's syndrome. J. Neurol. 259, 482-490.
26. Sieben, A., Van Langenhove, T., Engelborghs, S., Martin, J. J., Boon, P., Cras, P., De Deyn, P. P., Santens, P., Van Broeckhoven, C. and Cruts, M. (2012). The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 124, 353-372.
27. Singh, M. and Su, C. (2013). Progesterone and neuroprotection. Horm. Behav. 63, 284-290.
28. Sparks, D. L., Kryscio, R. J., Sabbagh, M. N., Ziolkowski, C., Lin, Y., Sparks, L. M., Liebsack, C. and Johnson-Traver, S. (2012). Tau is reduced in AD plasma and validation of employed ELISA methods. Am. J. Neurodegener. Dis. 1, 99-106.
29. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E. et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
30. Stein, D. G. (2011). Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience 191, 101-106.
31. Tsao, W., Jeong, Y. H., Lin, S., Ling, J., Price, D. L., Chiang, P. M. and Wong, P. C. (2012). Rodent models of TDP-43: recent advances. Brain Res. 1462, 26-39.
32. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106, 18809-18814.